Here's How Much $100 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth Today
Icon Q1 2025 Earnings Preview
Guardant Health Presents Data From Study Showing That Methylation-Based Shield MCD Test Showed High Specificity And Clinically Meaningful Sensitivity Across Ten Tumor Types
Labcorp Targets 10% EPS Growth With New Diagnostics and Acquisitions Strategy
Natera: Results Of DEFINE-HT Clinical Trial Shows Prospera Heart Is Predictive Of Clinical Outcomes And Outperforms Biopsy In Predicting Graft Dysfunction
QIAGEN Expands Digital PCR Portfolio With New Lentivirus Solutions To Strengthen Cell And Gene Therapy Quality Control
am00se : how to know our tp master
potsy52 am00se : Don’t ask tp/ he’ll let you know when good time to sell